By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision Antibody announced today it has been selected by SAIC-Frederick to supply antibody and antigen characterization for the National Cancer Institute's proteomics initiative.

Precision will assist SAIC-Frederick with the characterization of newly developed monoclonal antibodies, as well as antigens, as part of the NCI's Clinical Proteomic Technologies for Cancer program. The project will include surface plasmon resonance analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.